Literature DB >> 2645612

MRI of the paranasal sinuses and nasal cavity.

M D Shapiro1, P M Som.   

Abstract

In the evaluation of soft tissue masses of the paranasal sinuses and nasal cavity, MR has excelled, not only in sensitivity, but in specificity. Without question, MR has improved the diagnostic accuracy for distinguishing neoplasms from inflammatory diseases. This improved discrimination is primarily due to the combination of the superior soft tissue contrast of MRI and the widely disparate T2-relaxation values between the neoplasms and inflammatory processes indigenous to this anatomic area. MR's expanding role as the primary imaging modality for clinical problems in the sinonasal region will accompany the decrease in exam time and increase in spatial resolution. In the past few years there has been a rapid expansion in MRI's utility for a variety of clinical situations in the sinonasal region. This trend should accelerate, especially with the decrease in exam time and increase in spatial resolution that will accompany other expeditious technologic advancements.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645612

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  5 in total

Review 1.  Sinus disease in cystic fibrosis.

Authors:  G K Mak; N R Henig
Journal:  Clin Rev Allergy Immunol       Date:  2001-08       Impact factor: 8.667

2.  Magnetic resonance imaging in oncology.

Authors:  J E Husband; R Guy
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

3.  Nasal mucosal thickening simulating a tumor: potential for misdiagnosis in brain perfusion imaging.

Authors:  L G Flores; S Jinnouchi; S Nagamachi; T Ohnishi; S Futami; Y Okuda; N Tsuru; K Watanabe
Journal:  Ann Nucl Med       Date:  1996-08       Impact factor: 2.668

Review 4.  Diagnosis and management of sinusitis.

Authors:  K L Evans
Journal:  BMJ       Date:  1994-11-26

5.  Esthesioneuroblastoma in a young child.

Authors:  B Gül; S Kulaçoğlu; M Yüksel; H Doğan; A I Okten
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.